These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8585063)

  • 41. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
    Nieminen MS; Kupari M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
    Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency].
    Fortschr Med Monogr; 1993; 68():1-23. PubMed ID: 7728496
    [No Abstract]   [Full Text] [Related]  

  • 44. Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders.
    Wadworth AN; Brogden RN
    Drugs; 1991 Mar; 41(3):378-99. PubMed ID: 1711445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overall tolerance and safety of quinapril in clinical trials.
    Frank GJ; Knapp LE; McLain RW
    Angiology; 1989 Apr; 40(4 Pt 2):405-15. PubMed ID: 2650583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
    Banas JS
    Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates.
    Haleen SJ; Weishaar RE; Overhiser RW; Bousley RF; Keiser JA; Rapundalo SR; Taylor DG
    Circ Res; 1991 May; 68(5):1302-12. PubMed ID: 1850330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia.
    Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
    Int J Mol Med; 2000 Nov; 6(5):591-4. PubMed ID: 11029530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of treatment on survival in an animal model of chronic heart failure.
    Bastien N; Lambert C
    Am J Cardiol; 1998 Nov; 82(10A):50S-52S. PubMed ID: 9860360
    [No Abstract]   [Full Text] [Related]  

  • 51. Moexipril versus captopril in patients with mild to moderate hypertension.
    Stimpel M; Koch B; Jansen T; Fox A; Loh I
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):769-73. PubMed ID: 8961074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
    Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
    [No Abstract]   [Full Text] [Related]  

  • 53. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
    Jondeau G; Dib JC; Dubourg O; Bourdarias JP
    Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Newer ACE inhibitors. A look at the future.
    Salvetti A
    Drugs; 1990 Dec; 40(6):800-28. PubMed ID: 2078997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ACE inhibitors: review of four new agents.
    Binder SB
    Am Fam Physician; 1993 Oct; 48(5):851-7. PubMed ID: 8213415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
    Ma M; Watanabe K; Wahed MI; Inoue M; Sekiguchi T; Kouda T; Ohta Y; Nakazawa M; Yoshida Y; Yamamoto T; Hanawa H; Kodama M; Fuse K; Aizawa Y
    J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S51-4. PubMed ID: 11811359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats.
    Jacolot A; Tod M; Petitjean O
    Antimicrob Agents Chemother; 1996 Apr; 40(4):979-82. PubMed ID: 8849263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Captopril and quinapril reduce reactive oxygen species.
    van der Giet M; Erinola M; Zidek W; Tepel M
    Eur J Clin Invest; 2002 Oct; 32(10):732-7. PubMed ID: 12406020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
    Townend JN; Virk SJ; Qiang FX; Lawson N; Bain RJ; Davies MK
    Eur Heart J; 1993 Feb; 14(2):243-50. PubMed ID: 8383598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.